University of Cambridge > > CfEL's Enterprise Tuesday 2011/2012 > CfEL's Enterprise Tuesday 2011/2012: Recognising Opportunities

CfEL's Enterprise Tuesday 2011/2012: Recognising Opportunities

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Enterprise Tuesday.

The strap line, “Here to make millions of women pregnant”, seems to have captured the imagination of investors and customers alike for University spin-out Cambridge Temperature Concepts (CTC). On 8th November, Dr Shamus Husheer, CEO of CTC , will talk about how a young team came up with an innovation and (with sheer persistence and the ability to promote the idea) have successfully taken it to market. He and Robert Brady, active mentor and investor for technology start-ups, discuss how to galvanise belief in the merits of an idea and persuade investors it is worth the risk.

When? 8th November 2011. Registration is from 18:00. The lecture starts at 18:30. Networking from 20:00. Refreshments are provided.

Where? University of Cambridge Department of Engineering, LT0 , Trumpington Street, Cambridge

Registration: Please register online at

About Cambridge Temperature Concepts (CTC)

Cambridge Temperature Concepts Limited (CTC) is a spin-out from the University of Cambridge, commercialising an incredibly precise physiological temperature logging system initially applied to conception assistance ( DuoFertility consists of a wireless electronic sensor/datalogger, hand-held reader, PC software and server-side data analysis with feedback to the user and their health providers. Published data shows that six months of use is as effective as IVF , at 10% of the cost.

Guest speakers:

Dr Shamus Husheer CEO of Cambridge Temperature Concepts Limited (CTC)

Shamus founded the company with five other Cambridge graduates, as the inventor of the underlying technology and primary force in fundraising, development and commercialisation. As technical expert, he led the product development from a sheet of paper to internationally approved medical device selling direct to consumers in less than 18 months and for under £1M in total costs. Simultaneously as CEO he has orchestrated five Angel funding rounds, every one significantly over-subscribed, raising in excess of £2M and retaining majority ownership of the company with the founders throughout this process. The company now employs 15 people and sells internationally.

Robert Brady External Director, Cambridge IP

After a PhD in superconductivity, Robert worked as a fellow of Trinity College, Cambridge. There he published two studies in the journal Nature: on the electrolysis of copper sulfate solution (the copper electrodeposit is fractal), and on computer optimisation strategies gleaned from biological evolution. In 1985 Robert left his academic career to set up a company supplying software and services to the financial industry. The company listed on AIM in 2004, as Brady plc. Robert became a non-executive director in 2009. Robert’s first love has always been early stage technology companies. He is treasurer of the Cambridge Angels, a business angel group, and is an active mentor and investor for technology start-ups. He is a director of Brady (financial software), Cambridge IP (patent landscaping) and Hycagen (biodiesel).

For further information about the Enterprise Tuesday series, please see

This talk is part of the CfEL's Enterprise Tuesday 2011/2012 series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity